Table 2 Commonly adopted quality indicators for ACS

Aspirin on arrival

Upon admission

Process

Patients were prescribed aspirin at arrival/patients with ACS

7 [19, 20, 24, 26,27,28,29]

Time for primary PCI/timely performed PCI

Acute setting

Process

Time from first medical contact or admission to primary PCI/timely PCI for STEMI or NSTEMI

9 [11, 20, 21, 23, 24, 26,27,28,29]

Time for fibrinolytic therapy

Acute setting

Process

Patients underwent < 10 min in case of reperfusion with fibrinolysis

6 [11, 20, 24, 26, 28, 29]

Aspirin at discharge

During hospitalization / at discharge

Process

Patients were prescribed aspirin at discharge/patients with ACS

6 [19, 20, 24,25,26, 29]

High-intensity statins prescription

During hospitalization / at discharge

Process

Patients were prescribed high-intensity statins/patients with ACS

7 [11, 19, 20, 24, 26, 27, 29]

Beta-blocker prescription

During hospitalization / at discharge

Process

Patients were prescribed beta-blockers/patients with reduced LV function

8 [11, 19, 20, 24,25,26,27, 29]

ACEi/ARB prescription

During hospitalization / at discharge

Process

Patients were prescribed ACEi or ARBs/patients with reduced LV function

8 [11, 19, 20, 24,25,26,27, 29]

LVEF assessment

During hospitalization / at discharge

Process

Patients who underwent assessment of LV function/patients with ACS

6 [11, 19, 20, 24, 26, 27]

Mortality or readmission

–

Outcome

Short- (30-day) or long-term mortality for hospitalized patients with ACS

7 [11, 21, 22, 24, 26, 28, 29]